Eltrombopag

Cat. No.: PI496775612

Description: Eltrombopag is a drug of the class of thrombopoetine receptor agonists. Since 2010, the substance has also been approved in the EU, before that it was only approved in the US. In 2015, the indication of idiopatic thrombocytopenic purpura (ITP) was extended to include severe aplastical anemia (SAA), in which other therapies do not strike. No serious side effects have been observed, however side effects are very common.